Genprex, Inc.

GNPX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $7.8M $1.6M $6.7M $21.0M — — — —
Accounts Receivable — — $0 $34.9K $0 $127 $655 $9.3K
Inventory — — — — — — — —
Total Current Assets $8.4M $2.1M $7.5M $21.5M $39.1M $27.7M $3.0M $8.8M
Property, Plant & Equipment $0 $0 $7.9K $23.0K $48.6K $39.4K $44.7K $24.4K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — $0 $773.5K $702.1K $642.4K $601.6K $491.2K $379.5K
Total Assets $10.2M $4.1M $10.7M $25.1M $42.9M $31.4M $3.5M $9.3M
Liabilities
Accounts Payable $743.1K $1.1M $1.4M $442.9K $973.2K $193.0K $436.3K $295.1K
Total Current Liabilities $2.2M $2.5M $3.3M $2.8M $1.6M $450.7K $510.7K $387.8K
Long-Term Debt — — — — — — — —
Total Liabilities $2.2M $2.5M $3.3M $2.5M $1.6M $450.7K $510.7K $387.8K
Stockholders' Equity
Retained Earnings $-171.0M $-154.8M $-133.7M $-102.8M $-79.1M $-58.4M $-40.5M $-29.8M
Total Stockholders' Equity $8.0M $1.6M $7.4M $22.3M $41.3M $30.9M $3.0M $8.9M
← Newer Page 1 of 2 Older →